Information needs and awareness of diagnosis in patients with cancer receiving chemotherapy: a report from Greece

Iconomou, Gregoris; Viha, Anna; Koutra, Angelos; Vagenakis, Apostolos G; Kalofonos, Haralabos P
July 2002
Palliative Medicine;Jul2002, Vol. 16 Issue 4, p315
Academic Journal
This study assessed the information needs of Greek cancer patients and examined whether awareness of diagnosis had any impact on patients. One hundred patients were interviewed about overall and specific information needs, satisfaction, emotional distress, and quality of life. Patients exhibited a great desire for information overall. The need to have more information was high especially regarding the aftermath of chemotherapy, prognosis, how chemotherapy worked, and diagnosis. Patients were more satisfied with care but less satisfied with the information received. Only 37% knew they had cancer, especially the younger, the better educated, and those with breast cancer. Awareness was not related to satisfaction, emotional distress, or quality of life. Our findings suggest that Greek cancer patients need more factual information about their condition and management. Greek oncologists may feel freer to inform their patients about the diagnosis and other issues following their judgement, rather than employing the policy of concealing the truth.


Related Articles

  • The Cardinal's Flight. Gubili, Jyothirmai // Oncologist;Apr2012, Vol. 17 Issue 4, p585 

    The poem "The Cardinal's Flight," by Jyothirmai Gubili is presented. First Line: Inflammation; Last Line: Forgot to take Prednisone today.

  • Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Slevin, Maurice L.; Stubbs, Linda; Plant, Hilary J.; Wilson, Peter; Gregory, Walter M.; Armes, P. Joanne; Downer, Susan M. // BMJ: British Medical Journal (International Edition);6/2/90, Vol. 300 Issue 6737, p1458 

    Compares the responses of cancer patients with matched control group in assessing personal cost-benefit of chemotherapy in Great Britain. Acceptance of cancer patients on the small chance of benefit; Discussion with patients and relatives on treatment options; Categories on the minimal benefit...

  • Early changes in [[sup 18] F]FLT uptake after chemotherapy: an experimental study. Dittmann, Helmut; Dohmen, Matthias; Kehlbach, Rainer; Bartusek, Gabi; Pritzkow, Maren; Sarbia, Mario; Bares, Roland // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 11, p1462 

    This study evaluated the use of 3′-deoxy-3′-[[sup 18] F]fluorothymidine ([[sup 18] F]FLT) for monitoring of the early effects of anticancer chemotherapy on tumour cell proliferation. Cells derived from human oesophageal squamous cell carcinoma (OSC-1) were grown for 2 days and...

  • Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast... van Dam, Frits S.A.M.; Schagen, Suanne B.; Muller, Martin J.; Boogerd, Willem; Wall, Elsken; Fortuyn, Maria E. Droogleever; Rodenhuis, Sjoerd // JNCI: Journal of the National Cancer Institute;02/04/98, Vol. 90 Issue 3, p210 

    Presents a study which examined the high-dose chemotherapy in patients with breast cancer. Aims of the study; Methodology of the study; Results and discussion of the study.

  • Researchers Find Physiologic Evidence of Chemo Brain.  // Neurology Reviews;Dec2012, Vol. 20 Issue 12, p19 

    The article informs that according to researchers Chemotherapy could bring the changes in the brain that may affect the memory and concentration ability of the patients suffering from cancer.

  • Neurotoxic Complications of Chemotherapy in Patients with Cancer: Clinical Signs and Optimal Management. Verstappen, Carla C.P.; Heimans, Jan J.; Hoekman, Klaas; Postma, Tjeerd J. // Drugs;2003, Vol. 63 Issue 15, p1549 

    Neurotoxic side effects of chemotherapy occur frequently and are often a reason to limit the dose of chemotherapy. Since bone marrow toxicity, as the major limiting factor in most chemotherapeutic regimens, can be overcome with growth factors or bone marrow transplantation, the use of higher...

  • What does 'response' in cancer chemotherapy really mean? Watson, James V. // British Medical Journal (Clinical Research Edition);7/4/1981, Vol. 283 Issue 6283, p34 

    Examines the response of patients to cancer chemotherapy in Great Britain. Definition of a clinical response; Categorization of responses; Enumeration of current methods for oncological assessment.

  • Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Bull, Joan M.; Lees, David; Schuette, William; Jacqueline Whang-Peng; Smith, Rosalie; Bynum, Gaither; Atkinson, E. Ronald; Gottdiener, John S.; Gralnick, Harvey R.; Shawker, Thomas H.; DeVita Jr., Vincent T.; Bull, J M; Lees, D; Schuette, W; Whang-Peng, J; Smith, R; Bynum, G; Atkinson, E R; Gottdiener, J S; Gralnick, H R // Annals of Internal Medicine;Mar79, Vol. 90 Issue 3, p317 

    Fourteen patients with a variety of neoplasms not responsive to standard forms of therapy underwent whole body hyperthermia for a maximum 4 h at 41.8 degrees C. This was a phase-I cancer trial designed to develop whole body hyperthermia as an adjuvant to systemic chemotherapy. Intravenous...

  • Docetaxel-induced extravasation injury: a report of three cases. Harrison, B.R.; Ketts, J.R.; Schultz, M.Z.; Yackzan, S. // Journal of Oncology Pharmacy Practice;Sep2000, Vol. 6 Issue 3, p122 

    Reports on the three cases of docetaxel extravasation. Effect of chemotherapy drugs on cancer patients; Observation on patients with extravasation of docetaxel; Recommendations on the treatment of docetaxel extravasation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics